Topical and intralesional cidofovir: A review of pharmacology and therapeutic effects
- 1 November 1998
- journal article
- review article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 39 (5) , 741-745
- https://doi.org/10.1016/s0190-9622(98)70046-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of Verruca Vulgaris With Topical CidofovirPublished by American Medical Association (AMA) ,1997
- In vitro antiviral drug sensitivity of the Kaposiʼs sarcoma-associated herpesvirusAIDS, 1997
- Bioavailability and metabolism of cidofovir following topical administration to rabbitsAntiviral Research, 1997
- Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.Journal of Clinical Investigation, 1997
- Phenotypic Resistance of Herpes Simplex Virus Type 1 Strains Selected in Vitro with Antiviral Compounds and Combinations ThereofAntiviral Chemistry and Chemotherapy, 1996
- Treatment of Anogenital Papillomavirus Infections with an Acyclic Nucleoside Phosphonate AnalogueNew England Journal of Medicine, 1995
- Biochemical basis for increased susceptibility to Cidofovir of herpes simplex viruses with altered or deficient thymidine kinase activityAntimicrobial Agents and Chemotherapy, 1995
- Clinical pharmacokinetics of cidofovir in human immunodeficiency virus-infected patientsAntimicrobial Agents and Chemotherapy, 1995
- Successful treatment of a squamous papilloma of the hypopharynx‐esophagus by local injections of (S)‐1‐(3‐hydroxy‐2‐phosphonylmethoxypropyl)cytosineJournal of Medical Virology, 1995
- (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replicationAntimicrobial Agents and Chemotherapy, 1988